Literature DB >> 31356173

IL-27 and TCR Stimulation Promote T Cell Expression of Multiple Inhibitory Receptors.

Jonathan H DeLong1, Aisling O'Hara Hall1,2, Matt Rausch3, Devapregasan Moodley3, Joseph Perry1, Jeongho Park1, Anthony T Phan1, Daniel P Beiting1, Ross M Kedl4, Jonathan A Hill3, Christopher A Hunter5.   

Abstract

Inhibitory receptors (IR) are a diverse group of cell surface molecules that modulate T cell activation, but there are gaps in our knowledge of the cell-extrinsic factors that regulate their expression. The present study found that in vivo overexpression of IL-27 in mice led to increased T cell expression of PD-L1, LAG-3, TIGIT, and TIM-3. In vitro, TCR stimulation alone promoted expression of multiple IRs, whereas IL-27 alone induced expression of PD-L1. However, the combination of intermediate TCR stimulation and IL-27 resulted in synergistic induction of LAG-3, CTLA-4, and TIGIT. In vivo, infection with Toxoplasma gondii resulted in parasite-specific effector T cells that expressed high levels of IR, and at local sites of infection where IL-27 production was highest, IL-27 was required for maximal effector cell expression of PD-L1, LAG-3, CTLA-4, and TIGIT. Together, these results affirm the critical role of TCR signals in the induction of IR expression but find that during infection, IL-27 promotes T cell expression of IR.
Copyright © 2019 The Authors.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31356173      PMCID: PMC6994206          DOI: 10.4049/immunohorizons.1800083

Source DB:  PubMed          Journal:  Immunohorizons        ISSN: 2573-7732


  64 in total

1.  Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment.

Authors:  Atsunobu Takeda; Shinjiro Hamano; Atsushi Yamanaka; Toshikatsu Hanada; Tatsuro Ishibashi; Tak W Mak; Akihiko Yoshimura; Hiroki Yoshida
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

Review 2.  IL-10: the master regulator of immunity to infection.

Authors:  Kevin N Couper; Daniel G Blount; Eleanor M Riley
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

3.  Phenotypic changes induced by interferon in resting T cells: major enhancement of Ly-6 antigen expression.

Authors:  F J Dumont; R G Palfree; L Z Coker
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

4.  Type I interferon is the primary regulator of inducible Ly-6C expression on T cells.

Authors:  A J Schlueter; A M Krieg; P de Vries; X Li
Journal:  J Interferon Cytokine Res       Date:  2001-08       Impact factor: 2.607

Review 5.  The immunobiology of interleukin-27.

Authors:  Hiroki Yoshida; Christopher A Hunter
Journal:  Annu Rev Immunol       Date:  2015       Impact factor: 28.527

6.  Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10.

Authors:  Jason S Stumhofer; Jonathan S Silver; Arian Laurence; Paige M Porrett; Tajie H Harris; Laurence A Turka; Matthias Ernst; Christiaan J M Saris; John J O'Shea; Christopher A Hunter
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

7.  IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells.

Authors:  Stefan Pflanz; Jackie C Timans; Jeanne Cheung; Rency Rosales; Holger Kanzler; Jonathan Gilbert; Linda Hibbert; Tatyana Churakova; Marilyn Travis; Elena Vaisberg; Wendy M Blumenschein; Jeanine D Mattson; Janet L Wagner; Wayne To; Sandra Zurawski; Terrill K McClanahan; Daniel M Gorman; J Fernando Bazan; Rene de Waal Malefyt; Donna Rennick; Robert A Kastelein
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

8.  A role for IL-27p28 as an antagonist of gp130-mediated signaling.

Authors:  Jason S Stumhofer; Elia D Tait; William J Quinn; Nancy Hosken; Björn Spudy; Radhika Goenka; Ceri A Fielding; Aisling C O'Hara; Yi Chen; Michael L Jones; Christiaan J M Saris; Stefan Rose-John; Daniel J Cua; Simon A Jones; Merle M Elloso; Joachim Grötzinger; Michael P Cancro; Steven D Levin; Christopher A Hunter
Journal:  Nat Immunol       Date:  2010-11-07       Impact factor: 25.606

9.  Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.

Authors:  Shawn D Blackburn; Haina Shin; W Nicholas Haining; Tao Zou; Creg J Workman; Antonio Polley; Michael R Betts; Gordon J Freeman; Dario A A Vignali; E John Wherry
Journal:  Nat Immunol       Date:  2008-11-30       Impact factor: 25.606

10.  B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections.

Authors:  Trupti Joshi; Susana Rodriguez; Vladimir Perovic; Ian A Cockburn; Simona Stäger
Journal:  PLoS Pathog       Date:  2009-05-15       Impact factor: 6.823

View more
  24 in total

Review 1.  Cytokines and transcription factors in the differentiation of CD4+ T helper cell subsets and induction of tissue inflammation and autoimmunity.

Authors:  Mathias Pawlak; Allen W Ho; Vijay K Kuchroo
Journal:  Curr Opin Immunol       Date:  2020-10-08       Impact factor: 7.486

2.  Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer.

Authors:  Keren Jia; Yang Chen; Yu Sun; Yajie Hu; Lei Jiao; Jie Ma; Jiajia Yuan; Changsong Qi; Yanyan Li; Jifang Gong; Jing Gao; Xiaotian Zhang; Jian Li; Cheng Zhang; Lin Shen
Journal:  BMC Med       Date:  2022-07-11       Impact factor: 11.150

3.  Impact of secondary TCR engagement on the heterogeneity of pathogen-specific CD8+ T cell response during acute and chronic toxoplasmosis.

Authors:  Lindsey A Shallberg; Anthony T Phan; David A Christian; Joseph A Perry; Breanne E Haskins; Daniel P Beiting; Tajie H Harris; Anita A Koshy; Christopher A Hunter
Journal:  PLoS Pathog       Date:  2022-06-21       Impact factor: 7.464

4.  CD40 Agonist Overcomes T Cell Exhaustion Induced by Chronic Myeloid Cell IL-27 Production in a Pancreatic Cancer Preclinical Model.

Authors:  Adam L Burrack; Meagan R Rollins; Ellen J Spartz; Taylor D Mesojednik; Zoe C Schmiechen; Jackson F Raynor; Iris X Wang; Ross M Kedl; Ingunn M Stromnes
Journal:  J Immunol       Date:  2021-02-08       Impact factor: 5.426

Review 5.  Immune Checkpoint Inhibitors in Peripheral T-Cell Lymphoma.

Authors:  Xi Chen; Wanchun Wu; Wenwen Wei; Liqun Zou
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

Review 6.  Tim-3 finds its place in the cancer immunotherapy landscape.

Authors:  Nandini Acharya; Catherine Sabatos-Peyton; Ana Carrizosa Anderson
Journal:  J Immunother Cancer       Date:  2020-06       Impact factor: 13.751

7.  Endogenous Glucocorticoid Signaling Regulates CD8+ T Cell Differentiation and Development of Dysfunction in the Tumor Microenvironment.

Authors:  Nandini Acharya; Asaf Madi; Huiyuan Zhang; Max Klapholz; Giulia Escobar; Shai Dulberg; Elena Christian; Michelle Ferreira; Karen O Dixon; Geoffrey Fell; Katherine Tooley; Davide Mangani; Junrong Xia; Meromit Singer; Marcus Bosenberg; Donna Neuberg; Orit Rozenblatt-Rosen; Aviv Regev; Vijay K Kuchroo; Ana C Anderson
Journal:  Immunity       Date:  2020-09-15       Impact factor: 31.745

8.  T cells drive negative feedback mechanisms in cancer associated fibroblasts, promoting expression of co-inhibitory ligands, CD73 and IL-27 in non-small cell lung cancer.

Authors:  Richard A O'Connor; Vishwani Chauhan; Layla Mathieson; Helen Titmarsh; Lilian Koppensteiner; Irene Young; Guilia Tagliavini; David A Dorward; Sandrine Prost; Kevin Dhaliwal; William A Wallace; Ahsan R Akram
Journal:  Oncoimmunology       Date:  2021-07-08       Impact factor: 8.110

9.  Type I Interferon Transcriptional Network Regulates Expression of Coinhibitory Receptors in Human T cells.

Authors:  David Hafler; Tomokazu Sumida; Shai Dulberg; Jonas Schupp; Helen Stillwell; Pierre-Paul Axisa; Michela Comi; Matthew Lincoln; Avraham Unterman; Naftali Kaminski; Asaf Madi; Vijay Kuchroo
Journal:  Res Sq       Date:  2021-06-08

10.  Serum IL27 in Relation to Risk of Hepatocellular Carcinoma in Two Nested Case-Control Studies.

Authors:  Jian-Min Yuan; Yue Wang; Renwei Wang; Hung N Luu; Jennifer Adams-Haduch; Woon-Puay Koh; Yu-Tang Gao; Jaideep Behari; Michael T Lotze
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-11-17       Impact factor: 4.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.